---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-23-000056"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-09T01:14:21.882191+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Haemonetics reports Q2 FY2024 results; specific figures not included in filed document

## Summary
- Earnings release dated November 2, 2023 for quarter and first half ended September 30, 2023.
- Press release was furnished as Exhibit 99.1 but its text was not provided in the filing.
- No financial metrics, guidance changes, or segment data available for analysis.

## SEC filing metadata
- accession: 0000313143-23-000056
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314323000056/0000313143-23-000056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314323000056/hae-20231102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-23-000056
- JSON: https://secwatch.observer/filing/0000313143-23-000056.json
- Plain text: https://secwatch.observer/filing/0000313143-23-000056.txt

## Key facts
- Earnings Releases
  HAEMONETICS CORP reported financial results for the second quarter ended September 30, 2023.
  - Period: the second quarter ended September 30, 2023
  - Result: reported results
  source text: On November 2, 2023, Haemonetics Corporation issued a press release announcing financial results for the second quarter ended September 30, 2023 and first half of fiscal 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/313143/000031314323000056/0000313143-23-000056-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.